The Renalogic Difference

Known as the silent killer, chronic kidney disease (CKD) hides within a population often until the disease is advanced and results in emergent dialysis treatment. Self-funded employers need dynamic and effective resources to protect their members and plan assets before it’s too late, and they are faced with unexpected or increased costs, an overall poor workforce health, or even death.

We provide the most comprehensive CKD risk management and dialysis cost-containment methodology to improve member health and protect plan assets.

Our Vision

To transform the imbalanced healthcare market into a more equitable, efficient and transparent industry for all stakeholders.

Our Mission

To be the industry leader for kidney disease risk management and dialysis cost containment, and provide indispensable support, services and solutions for self-funded plans and their members.

Our Promise

To deliver guaranteed impact, every day, for self-funded plans, members and the healthcare market.



of participating members have successfully avoided dialysis.



We’ve saved nearly $1 billion dollars for clients through ImpactProtect while significantly improving participating members’ health and vitality.



Average client savings off contracted dialysis rates.

It’s time to think proactively about CKD risks and dialysis costs.


Kevin Weinstein

Chief Executive Officer

Kevin brings a deep background in successfully growing investor-backed, innovative healthcare companies. Immediately prior to joining Renalogic, he was President of population health for a technology company, Azara Healthcare. Previously he has served as CEO and in other executive positions at a variety of pioneering healthcare companies including Allscripts (NASDAQ: MDRX), ZirMed (now Waystar), and Valence Health (now part of Evolent Health (NYSE: EVH). Kevin joined Renalogic in July 2021 and serves on the company’s Board of Directors.

Read Bio Close

Mark Masson

President and Chief Operating Officer

Mark joined Renalogic in 2018, bringing with him over 23 years of diversified healthcare experience that includes operations, sales & marketing, product development, mergers and acquisitions. His academic credentials include earning a B.A. and Master of Business Administration. As President, Mark leads Renalogic’s Product and Process teams, which include Quality, Strategy, IT and Data, Cost Containment, and the Kidney Dialysis Avoidance Program (KDAP).

Read Bio Close

Scott Vold

Chief Commercial Officer

Scott is an experienced entrepreneur and operator of investor-backed healthcare companies. In August 2021, Scott joined Renalogic as the company’s Chief Commercial Officer. Prior to Renalogic, Scott drove an industry-wide effort to redefine the physician referral management process as Founder, CEO, and Chairman of Fibroblast, Inc., a venture-funded company he led from concept to successful acquisition by Cerner Corporation (NASDAQ: CERN) in October 2020. Scott began his career as an attorney representing Fortune 1000 companies and financial services firms in complex commercial litigation.

Read Bio Close

Jay Ginsberg, MD, MMM

Chief Medical Officer

Dr. Ginsberg joined Renalogic as Chief Medical Officer in 2012 and has been instrumental in developing algorithms to identify undiagnosed renal patients and protocols to help prevent progression of renal disease. Dr. Ginsberg served as Chairman of the Department of Nephrology at Lawrence and Memorial Hospital in New London, CT and Backus Hospital in Norwich, CT. He also served as medical director of two dialysis units.

Read Bio Close

John R. Christiansen

Executive Vice President of Legal Risk & Strategy

In 2021, John was named Executive Vice President of Legal Risk and Strategy. He is responsible for legal risk and compliance, legal research and analysis, support, and quality assurance in the development and implementation of Renalogic’s services. This includes expert support and analysis on all issues related to dialysis cost containment and chronic kidney disease management, from ERISA plan administration and appeals to PPACA reforms affecting cost containment options, Medicare Secondary Payor, state licensing and payment laws, and PPO and other network contract drafting and interpretation.

Read Bio Close

Kyle Bersnak

Vice President of Finance

In August 2021, Kyle joined Renalogic as the company’s Vice President of Finance. Kyle brings more than 15 years’ experience leading finance for large companies in the services industry, including one of the largest independent third-party administrators (TPAs) in the US. He has effectively converted business and financial data into strategy. Kyle’s proven history of implementing process improvements and optimizing financial results benefits Renalogic and our clients.

Read Bio Close

Sally Reppucci

Vice President of Projects & Quality

Sally has been with Renalogic since 2010, bringing with her over a decade of healthcare program management. Sally is an integral part of our success as she consistently addresses our company’s most prioritized needs from idea to successful completion. In addition to her role as the Vice President Projects and Quality, Sally works with fellow Executive Team members to identify, define, and execute strategic and organizational health initiatives.

Read Bio Close

Forrest Barnes III

Vice President of Data and Technology

Forrest joined Renalogic in 2021 as Vice President of Data and Technology. Forrest is an Information Technology leader with more than 20 years’ experience in Healthcare, Financial Services, and Insurance sectors. Prior to joining Renalogic, Forrest served as Director of Information Technologies for Evolution Health, Director of Operations for Blue Cross Blue Shield Insurance and as a Customer Engagement Executive for GuideIt. Forrest has a strong background in compliance, security, network architecture, and innovative technology solutions.

Read Bio Close

Team Member Name

Job Position

Placeholder content Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.